📰 Inbal Chen News
Inbal Chen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Inbal Chen. Real-time updates on events, politics, business and more.
January 8, 2024
Libtayo is a leading PD-1 inhibitor that has shown efficacy in the treatment of certain patients with cutaneous squamous cell carcinoma, advanced basal cell carcinoma, advanced non-small cell lung...
January 8, 2024
Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets, announced today their exclusive multi-national agreement …
January 8, 2024
ZUG, Switzerland, Jan. 8, 2024 /PRNewswire/ -- Medison Pharma ('Medison'), a global pharma company focused on providing access to highly innovative therapies to patients in international markets, announced today their exclusive multi-national agreement with Regeneron Ireland
September 29, 2023
/PRNewswire/ -- Today, Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in...
January 10, 2023
Sarah Otten Joins Medison Pharma as VP, GM Americas Region - read this article along with other careers information, tips and advice on BioSpace
January 9, 2023
Sarah Otten will lead Medisons Americas region covering Canada and Latin America. Sarah brings vast geographical expansion experience in internat...
January 9, 2023
/PRNewswire/ -- Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international...
November 29, 2022
With this latest expansion, Medison's global footprint is now extended across Israel, Central and Eastern Europe, Canada, Asia-Pacific and Latin America, offering patients in international markets improved access to highly innovative therapies. PETACH TIKVAH, Israel, Nov. 9, 2022 /PRNewswire/ -- Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets, today announced the addition of South an...
November 28, 2022
With this latest expansion, Medison's global footprint is now extended across Israel, Central and Eastern Europe, Canada, Asia-Pacific and Latin America, offering patients in international markets improved access to highly innovative therapies. PETACH TIKVAH, Israel, Nov. 9, 2022 /PRNewswire/ -- Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets, today announced the addition of South an...
November 10, 2022
Medison Pharma Announces Expansion of the Multi-Territorial Agreement with Immunocore into Latin America - read this article along with other careers information, tips and advice on BioSpace